CAR:

Jia Xu1,2,3, Zhaozhao Chen1,2,3, Liman Su1,2,3

  • 1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan, 430022, China.

PubMed
概括

活体CAR-T疗法通过直接在体内重新编程T细胞,为传统CAR-T疗法提供了更有效和更经济的替代方案. 这种方法旨在使先进的细胞疗法更容易获得,并为患有血液癌症的患者准备好使用.